Evidence map›Paper›PMID 36187733›Full record

ArticleInternational journal of dentistry2022

OSA Wellness Scale (OWS): A New Health-Related Quality of Life Test in Obstructive Sleep Apnea Patients Treated with Mandibular Advancement Device.

Domenico Ciavarella, Alessandra Campobasso, Laura Guida, Angela Pia Cazzolla, Graziano Montaruli, Fabrizio Corlianò, Luigi Romano, Michele Cassano, Michele Tepedino, Giuseppe Burlon

Abstract read
In one paragraph

Article in International journal of dentistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Domenico CiavarellaDepartment of Clinical and Experimental Medicine, University of Foggia, Clinica Odontoiatrica Via Rovelli 50, Foggia 71122, Italy.ORCID https://orcid.org/0000-0003-3114-6048
Alessandra CampobassoDepartment of Clinical and Experimental Medicine, University of Foggia, Clinica Odontoiatrica Via Rovelli 50, Foggia 71122, Italy.ORCID https://orcid.org/0000-0003-4726-8816
Laura GuidaDepartment of Clinical and Experimental Medicine, University of Foggia, Clinica Odontoiatrica Via Rovelli 50, Foggia 71122, Italy.ORCID https://orcid.org/0000-0003-1454-0684
Angela Pia CazzollaDepartment of Clinical and Experimental Medicine, University of Foggia, Clinica Odontoiatrica Via Rovelli 50, Foggia 71122, Italy.ORCID https://orcid.org/0000-0003-0842-7351
Graziano MontaruliDepartment of Clinical and Experimental Medicine, University of Foggia, Clinica Odontoiatrica Via Rovelli 50, Foggia 71122, Italy.
Fabrizio CorlianòDepartment of Otolaryngology Head and Neck Surgery, San Bassiano Hospital, Via Dei Lotti 40, Bassano Del Grappa (VI) 36061, Italy.ORCID https://orcid.org/0000-0001-6696-3959
Luigi RomanoDepartment of Otolaryngology Head and Neck Surgery, San Bassiano Hospital, Via Dei Lotti 40, Bassano Del Grappa (VI) 36061, Italy.
Michele CassanoDepartment of Clinical and Experimental Medicine, University of Foggia, Clinica Odontoiatrica Via Rovelli 50, Foggia 71122, Italy.ORCID https://orcid.org/0000-0002-2293-2832
Michele TepedinoDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, V.le S.Salvatore, L'Aquila 67100, Italy.
Giuseppe BurlonDepartment of Clinical and Experimental Medicine, University of Foggia, Clinica Odontoiatrica Via Rovelli 50, Foggia 71122, Italy.ORCID https://orcid.org/0000-0002-6746-2993

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To present a new short self-test, called the OSA wellness scale (OWS), for assessing the health-related quality of life (HRQoL) changes in obstructive apnea syndrome (OSA) patients treated with mandibular advancement device (MAD). Methods: 51 OSA patients (8 women and 43 men, mean age 52.3) treated with a fully customizable MAD device (Protrusor) were retrospectively enrolled. Each patient received a home sleep apnea testing (HSAT) at baseline (T0) and after three months of MAD treatment (T1). Two self-test evaluations, the Epworth sleepiness scale (ESS), and OWS were also submitted at T0 and T1. The OWS was a short self-test of 8 questions for evaluating the daytime HRQoL. Patients gave an assessment from 0 to 3 for each question. At the end of the questionnaire, the patients had a score from 0 to 24, resulting from the sum of all 8 scores. The higher the score, the greater the patient's perceived state of discomfort. Results: At T1, a significant decrease in the oxygen desaturation index (ODI) and apnea-hypopnea index (AHI) was shown ( Conclusion: The OWS could be a useful method to verify and numerically compare the perceived quality of life in OSA patients, before and after MAD therapy.

Identifiers

PMID36187733
PMCPMC9519331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.